Hey, try this archetypal nightmare out for size …
Youʼre in a room. Speaking. There are people there — hundreds and hundreds of people. They are not particularly friendly. Actually, they are hostile. You have displeased them. You had made certain unsubstantiated claims about something they know a great deal about. Yes, they are experts. They know exactly how to determine what is truth. And what is …
Then you wake up. Covered in sweat …
This is pretty much the scenario Theranos CEO and founder Elizabeth Holmes is going to face on Monday in Philadelphia, at the American Association for Clinical Chemistry’s 68th Annual Scientific Meeting & Clinical Lab Expo.
Holmes will present, for the first time and in front of hundreds of lab experts, “reproducibility and correlation data” for the blood-testing technology her company claims to have developed but has never proven to the satisfaction of the scientific community. Holmes will also “share data to demonstrate the precision and accuracy” of its tests.
Those tests can ostensibly be performed using only a small amount of capillary blood from a patient’s finger, instead of the traditional tubes-full taken from a vein.
But a Wall Street Journal investigation characterized those claims as dubious. Later, a Theranos lab in California was found by its regulator to be so deficient as to represent a threat to the life of patients. And this month, regulators suspended the lab’s license and banned Holmes from owning, operating or directing a blood-testing lab for two years. (The company has until early September to appeal the government’s decision, and the suspensions don’t take place Read More …
Source:: Future of You